FDA this week approved its first genotyping test for patients with hepatitis C virus (HCV), Abbott’s RealTime HCV Genotype II. The test can differentiate genotypes ...

Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer We performed a retrospective ...

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health Assays for genomic analysis of plasma cell-free DNA (cfDNA) ...

Mass General Brigham researchers developed and evaluated a rapid genotyping test for patients who present with a central nervous system lesion, eliminating need for an invasive surgical biopsy in ...

Diagnostic company Cue Health announced on Thursday that it will create an Omicron-genotyping COVID-19 test. The test will be used in professional care settings to specifically detect the Omicron ...

As the science and technology behind genomic sequencing progresses, high-throughput molecular testing has increasingly become a crucial tool in identifying diseases in their earliest stages. Despite ...

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. ("DiamiR"), a developer of innovative blood-based diagnostic tests for brain health and ...

In previous articles of this series, we’ve discussed several aspects of the hepatitis C virus including the nature of the infection and its distribution both globally and in the United States. Most ...

Aptorum (APM) stock underwent a massive rally on Thursday after the biopharmaceutical company announced Clinical Laboratory Evaluation Program (CLEP) Test Approval for blood testing company DiamiR ...

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and ...